Skip to main content

Month: September 2021

VYNE Therapeutics to Present at the H.C. Wainwright Annual Investment Conference

BRIDGEWATER, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually from September 13th – 15th. The presentation will take the form of a fireside chat, which will be available on demand here beginning September 13th at 7:00 AM (ET) and archived for 90 days. Management will also be available for 1-on-1 meetings with investors.Date: September 13Time: On Demand, beginning at 7:00 AM (ET)Webcast: VYNE Fireside ChatFor more information about the 23rd Annual Global Investment Conference, please visit the H.C. Wainwright conference website https://hcwevents.com/annualconference/ About VYNE Therapeutics Inc.VYNE’s...

Continue reading

TransUnion: New Research Explores Technological and Data Barriers to More Automated, Inclusive Credit Union Lending

Research brief offers loan growth and inclusion strategies to navigate the pandemic economy CHICAGO, Sept. 08, 2021 (GLOBE NEWSWIRE) — As the credit union industry rebounds from the unique set of challenges presented by the COVID-19 pandemic, many community financial institutions are recalibrating their growth strategies with an eye toward bolstering inclusive lending efforts. Trended and alternative data can play a key role in supporting those initiatives and a new research brief from Filene Research Institute and TransUnion (NYSE: TRU), examines how credit unions can adapt lending strategies to better compete with the evolving competitive landscape and expand financial inclusion efforts. “Credit unions have long aimed to provide access to financial services for the communities they serve. Many of these institutions are also looking...

Continue reading

Rockridge Commences Exploration Program at the Knife Lake Copper Project, Saskatchewan

VANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) — Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce it has commenced its field program at the Knife Lake Copper Project located in Saskatchewan, Canada (the “Knife Lake Project” or “Property”). The Knife Lake Project, consisting of 81 claims totaling 55,471 hectares (137,069 acres), is an advanced-stage copper, silver, zinc and cobalt exploration property in Saskatchewan host to the Knife Lake Deposit. Knife Lake VMS Project Location Map:https://www.rockridgeresourcesltd.com/_resources/images/Knife-Lake-Region-20210331-003.jpg Crews have commenced a helicopter-borne electromagnetic (EM) and horizontal magnetic gradiometer geophysical survey utilizing Geotech Ltd.’s VTEM Plus System. The 610 line...

Continue reading

Aeterna Zentaris to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website. A video webcast of the presentation will be available for viewing on-demand beginning Monday, September 13,...

Continue reading

Caladrius Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BASKING RIDGE, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that David J. Mazzo, PhD, President and CEO of Caladrius, will provide a corporate update and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13-15, 2021. The presentation will be available on-demand through the H.C. Wainwright conference portal, starting at 7:00 a.m. ET on Monday, September 13, 2021. If you are an institutional investor and would like to listen to the Company’s presentation, please click on the following link to register for the conference: https://hcwevents.com/annualconference/. About...

Continue reading

Atos releases new version of its satellite power testing solution and signs up customer OHB

Paris, France and Washington D.C., United States – September 8, 2021 – Atos today announces the new version of its ProUST UniverSAS® satellite power testing system which has been upgraded as part of the General Support Technology Program (GSTP) of the European Space Agency (ESA). Developed with and by international experts, the new version of Atos’ solution has been delivered to its first customer: OHB System, a European leader in the fields of space technology and services for satellites and security. The new version of this solution is an environmental breakthrough in the sector as it significantly increases efficiency and at the same time decreases customers’ carbon footprint. ProUST UniverSAS® is a reliable SCOE1 solution for powering, monitoring and testing satellites’ power subsystems during assembly, integration and test, as well...

Continue reading

FuelPositive Corp. Featured in Syndicated Broadcast Covering Company’s Hiring of NH3 Technology Patent Co-Inventor Dr. Ghassan Chehade to Lead Prototype Manufacturing

LOS ANGELES, Sept. 08, 2021 (GLOBE NEWSWIRE) — via InvestorWire — FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF), a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements, today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio press release covers FuelPositive’s recent announcement that it has hired engineer Dr. Ghassan Chehade, one of the co-inventors named on the provisional patent of the company’s technology that will produce carbon-free ammonia (NH3), as Lead Project Engineer. To hear the audio production, visit: https://nnw.fm/frM0k To read the original...

Continue reading

Werewolf Therapeutics to Present at H. C. Wainwright Global Investment Conference

CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced it will present at the H. C. Wainwright 23rd Annual Global Investment Conference on September 13-15. Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf, will provide an overview of the company, which will be available on-demand beginning September 13 at 7:00 am EDT and will be archived for 90 days. A link to the webcast will be available at https://investors.werewolftx.com/news-and-events/events. About Werewolf Therapeutics, Inc. Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the...

Continue reading

Josh Wilhelm Joins PetVivo Holdings, Inc. as the Director of Manufacturing

Josh WilhelmDirector of Islet Manufacturing and R&D at the Schulze Diabetes Institute (“SDI”)MINNEAPOLIS, MN, US, Sept. 08, 2021 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that Josh Wilhelm has accepted a position with the Company as its new Director of Manufacturing. “We are incredibly fortunate to have secured a manufacturing professional such as Josh who possesses expertise in cGMP manufacturing, process engineering, and quality systems,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “Josh is an experienced professional in assembling, coordinating and training manufacturing teams, and has already brought...

Continue reading

Triumph Gold Announces Completion of Exploration Drilling at the Freegold Mountain Project, Yukon

Figure 1Freegold Mountain Project location Map and area of 2021 drilling program.Photo 1N21-01 at 19m – Oxidized limonite after pyrite skarn replacement mineralization within YTT (Nucleus Deposit).Photo 2N21-02 at 114.20m – Epithermal-style quartz-pyrite-arsenopyrite veinlet within argillic altered YTT (Nucleus Deposit)Photo 3N21-05 at 174.14m – Semi-massive sulphide (marcasite +/- pyrite dominant) replacement within iron carbonate altered YTT (Big Creek South Fault area).Photo 4O21-01 at 159.8m – Epithermal style chalcopyrite-molybdenite-bornite veinlet cutting Microgranite and YTT (Orbit Zone).Photo 5RVD21-03 at 411.50m – Epithermal style scheelite and chalcopyrite WAu breccia mineralization within argillic altered Revenue granodiorite.Photo...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.